OTCMKTS:PVCT Provectus Biopharmaceuticals - PVCT Short Interest Ratio & Short Volume Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.13 0.00 (0.00%) (As of 01/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.13▼$0.1350-Day Range$0.06▼$0.1852-Week Range$0.03▼$0.19Volume121,846 shsAverage Volume209,587 shsMarket Capitalization$53.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Short Interest DataCurrent Short Volume9,700 sharesPrevious Short Volume100 sharesChange Vs. Previous Month+9,600.00%Dollar Volume Sold Short$1,286.71Short Interest Ratio / Days to Cover0.0Last Record DateJanuary 15, 2023Outstanding Shares419,497,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume121,846 sharesAverage Trading Volume209,587 sharesToday's Volume Vs. Average-41.86% Short Selling Provectus Biopharmaceuticals ? Sign up to receive the latest short interest report for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPVCT Short Interest Over TimePVCT Days to Cover Over TimePVCT Percentage of Float Shorted Over Time Provectus Biopharmaceuticals (OTCMKTS:PVCT) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20239,700 shares $1,286.71 +9,600.0%N/A0 $0.13 12/30/2022100 shares $10.83 -99.0%N/A0 $0.11 12/15/202210,000 shares $1,099.00 -66.6%N/A0 $0.11 11/30/202229,900 shares $2,780.70 -45.5%N/A0 $0.09 11/15/202254,900 shares $2,843.82 +54,800.0%N/A0.1 $0.05 10/31/2022100 shares $5.00 No ChangeN/A0 $0.05 10/15/2022100 shares $4.85 No ChangeN/A0 $0.05 9/30/2022100 shares $4.90 -99.6%N/A0 $0.05 9/15/202225,500 shares $1,351.50 +8.5%N/A0.1 $0.05 8/31/202223,500 shares $1,280.75 +2,511.1%N/A0.1 $0.05 8/15/2022900 shares $49.50 +80.0%N/A0 $0.06 7/31/2022500 shares $29.00 +400.0%N/A0 $0.06 7/15/2022100 shares $5.99 -99.6%N/A0 $0.06 6/30/202226,200 shares $1,419.28 +26,100.0%N/A0.1 $0.05 6/15/2022100 shares $5.30 -96.8%N/A0 $0.05 5/31/20223,100 shares $186.00 -54.4%N/A0 $0.06 5/15/20226,800 shares $357.68 +3,300.0%N/A0 $0.05 4/30/2022200 shares $12.28 +100.0%N/A0 $0.06 4/15/2022100 shares $5.86 No ChangeN/A0 $0.06 3/31/2022100 shares $6.74 No ChangeN/A0 $0.07 3/15/2022100 shares $6.92 -96.7%N/A0 $0.07 2/28/20223,000 shares $206.70 +2,900.0%N/A0 $0.07 2/15/2022100 shares $7.00 -98.7%N/A0 $0.07 1/31/20227,700 shares $500.50 -85.4%N/A0 $0.07 1/15/202252,600 shares $3,682.00 +39.2%N/A0.1 $0.07 12/31/202137,800 shares $2,079.00 +37,700.0%N/A0 $0.06 12/15/2021100 shares $5.03 -93.8%N/A0 $0.05 11/30/20211,600 shares $85.76 -61.0%N/A0 $0.05 11/15/20214,100 shares $213.61 +4,000.0%N/A0 $0.05 10/29/2021100 shares $5.62 -99.9%N/A0 $0.06 10/15/202190,700 shares $5,587.12 -24.6%N/A0.4 $0.06 9/30/2021120,300 shares $7,819.50 +55.8%N/A0.3 $0.07 9/15/202177,200 shares $4,863.60 -45.4%N/A0.2 $0.06 8/31/2021141,300 shares $8,619.30 -29.4%N/A0.1 $0.06 8/13/2021200,200 shares $13,913.90 -22.3%N/A0.5 $0.07 7/30/2021257,500 shares $17,896.25 +29.7%N/A1 $0.07 7/15/2021198,600 shares $13,902.00 +13.6%N/A0.4 $0.07 6/30/2021174,900 shares $11,980.65 -3.6%N/A0.7 $0.07 6/15/2021181,500 shares $12,668.70 -10.4%N/A0.3 $0.07 5/28/2021202,600 shares $14,911.36 +9.0%N/A0.5 $0.07 PVCT Short Interest - Frequently Asked Questions What is Provectus Biopharmaceuticals' current short interest? Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 9,700 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest. Is Provectus Biopharmaceuticals' short interest increasing or decreasing? Provectus Biopharmaceuticals saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 9,700 shares, an increase of 9,600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Provectus Biopharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Provectus Biopharmaceuticals: Bolt Biotherapeutics, Inc. (7.22%), SCYNEXIS, Inc. (2.85%), Hepion Pharmaceuticals, Inc. (0.73%), Infinity Pharmaceuticals, Inc. (1.32%), Applied Therapeutics, Inc. (0.44%), Pyxis Oncology, Inc. (4.10%), Unity Biotechnology, Inc. (3.99%), Bioxytran, Inc. (0.02%), Lantern Pharma Inc. (2.01%), and Alzamend Neuro, Inc. (4.54%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks. What does it mean to sell short Provectus Biopharmaceuticals stock? Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. PVCT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Provectus Biopharmaceuticals? A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further. How often is Provectus Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is January, 15 2023. More Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PVCT) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.